This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Amazon.com, Visa Inc., Apple Inc., Alibaba Group Holdings, and Microsoft are the largest five individual stock positions.
UNLNF HSB SCGLF LLOBF ABLZF CSCO UBS.PRDCL TCTZF GE COF-P VOD SCGLY PBR DDAIF AAWW 500180 MSFT NTES RIO WST AXP LEN.B COF-D COF-C COF-F HEI RTNTF ACA FAF BIDU HBCYF HCS.PRB ASML UL VOD UN BHPBF LLY GSK 0005 HDB GNE BHP 8035 TV SSYS VRNT AZN VALE3 MS.PRE FCX MS.PRF MS.PRG SIVB MS.PRA TOELY 6506 6503 VSH PEGA TOELF SMG SLB SMSN VECO PFIZER HCS HEI.A MS.PRI CFRUY MS.PRK RJD SCL SLB PFE RJF SMSD JD COF.PRG HD COF.PRH SSNLF SMFG COF.PRP UBS DG HDFCBANK COF.PRC HSBC COF.PRD ABEV SF.PRA COF.PRF SNN LFUS COST COF MRAAY LECO TORO SNY V PEP VODPF MRK MRAAF LLD5 SU LLD7 LLD6 LLD1 DPZ LLD2 INGR RIO BLT ULVR BECN YASKY SAN SAM AMX MS TSM YASKF INFY UTX BABA NVO JNJ LLDTF NVS BHPLF AZPN BAP LEN WMGI CFRHF RTPPF CLGX BOE AAPL INTC BBVA KBH POOL LLOY ITUB CRARF TTC LLPH ING SAP LLPK MEL LLPJ LLPE JPM LLPD LLPG HSEA HSEB LLPC CRARY 500680 ULSGF SMCAY BCS XOM CTRP COF.WS SEM WMT AMZN TCEHY ASML UNLYF SF BC94 BBD STE BRK.A GOOGL RIO BBL GLE BA EWBC PG NTCT YELP GOOG HRC CHE ASX HSBC.PRA ORCL QRVO PFZ BUD GEC MIELF SFN LYG UMPQ ABB VALE BHP MIELY CVX OCLCF SFB
Amazon.com, Alibaba Group Holdings, Visa Inc., Apple Inc., and Taiwan Semiconductor Manufacturing are the largest five individual stock positions.
BNPQY UNLNF LLOBF ABLZF CSCO ABBV GE COF-P VOD HXSCF SCGLY PBR DDAIF AAWW 500180 MSFT NTES HXSCL WST AXP LEN.B COF-D COF-C COF-F HEI FAF RYDAF BIDU TATAMOTORS ASML UL UN LLY GSK DPSGY ICICIBANK HDB GNE TV SSYS VRNT AZN MS.PRE MS.PRF MS.PRG RDSB SIVB RDSA MS.PRA 6506 6503 VSH PEGA CMCSK SAN SMG CAVM SBGSY SMSN VECO PFIZER HEI.A MS.PRI CFRUY MS.PRK KSU.PR RYDBF RJD ABBV PFE RJF SMSD JD COF.PRG HD COF.PRH SSNLF SIEGY SMFG COF.PRP SMFNF GS UBS DG HDFCBANK COF.PRC HSBC COF.PRD ABEV SF.PRA COF.PRF LFUS FANUF SNN CMCSA COST COF LECO TORO SNY V BLK PEP ETFC MRK 532174 LLD5 LLD7 LLD6 LLD1 DPZ LLD2 INGR ULVR BECN YASKY SAN AMX MS 500570 TSM YASKF INFY UTX VCISY BABA MTH NVO JNJ LAZ LLDTF NVS BASFY AZPN BAP CCV LEN WMGI CCZ CLGX BOE AAPL INTC SFTBY KSU BBVA KBH POOL LLOY MA ITUB PACW LVMUY TTC LLPH ING SAP LLPK MEL LLPJ LLPE JPM LLPD 8316 LLPG CCV.CL RHHBY LLPC CRARY 500680 TTM SMCAY BCS XOM CTRP COF.WS SEM WMT AMZN GSK ASML UNLYF SF BC94 WTFCW WTFC STE BBD BRK.A WTFCM GOOGL INFY MKSI BA EWBC PG NTCT YELP HRC GOOG CHE RDY ASX ORCL DIS QRVO PFZ BUD RDS.B GEC RDS.A IBN MIELF SFN LYG UMPQ WTFPP DPSTF ABB AZN MIELY CVX OCLCF SAN SFB
Les données d'activité du premier trimestre 2018, en dépit de conditions climatiques difficiles en Europe, confirment les bonnes tendances observées en 2017 et confortent la perspective de hausses du chiffre d'affaires et des résultats du Groupe pour l'ensemble de l'année.
SAO PAULO (Reuters) - United Arab Emirates’ sovereign wealth fund Mubadala Development Co [MUDEV.UL] is keen to acquire a majority stake in Brazilian suburban rail operator Supervia, controlled by conglomerate Odebrecht SA, three sources with knowledge of the matter said.
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to EPA:DG / VINCI on message board site Silicon Investor.